NAMI’s Ask the Expert Webinar: Antidepressants: How Do They Work?

Major Depressive Disorder continues to burden millions of people. Recognizing that many people will also benefit from therapy, this presentation will review antidepressants used in both short- and long-term treatment plans.

Learn from mood disorder expert Dr. Andrew Nierenberg as he reviews antidepressants used in both short- and long-term treatment plans. Dr. Nierenberg has published over 475 papers and has been listed in The Best Doctors in America for the treatment of mood and anxiety disorders in every edition since 1994.

His webinar will address the following questions: Do antidepressants work? What do they do? How do psychiatrists select which one to prescribe? What is the expected timeframe for response or symptom reduction? Can antidepressants prevent a potential symptom relapse? This webinar will also briefly discuss two new antidepressants, esketamine and brexanolone.

Following the presentation, Dr. Ken Duckworth, NAMI’s Medical Director, will moderate and facilitate an interactive Q&A session between our presenters and you, our audience.

Our Expert

Dr. Andrew Nierenberg

Andrew A. Nierenberg, M.D. graduated from the Albert Einstein College of Medicine of Yeshiva University, Bronx, NY. After completing his residency in psychiatry at New York University/Bellevue Hospital, he studied clinical epidemiology at Yale University as a Robert Wood Johnson Clinical Scholar. Dr. Nierenberg then joined the faculty at Harvard Medical School—first at McLean Hospital in Belmont, Massachusetts and then at Massachusetts General Hospital (MGH)—where he holds his current positions.

Dr. Nierenberg has published over 475 papers and has been listed in The Best Doctors in America for the treatment of mood and anxiety disorders in every edition since 1994. In 2000, he was awarded the Gerald L. Klerman Young Investigator Award and in 2014 the Gerald L. Klerman Senior Investigator Award by the Depression Bipolar Support Alliance. In 2013, Dr. Nierenberg was awarded the prestigious Brain and Behavior Research Foundation Colvin Prize for outstanding achievement in mood disorders research.